For category c (de novo mutations), in addition to the data from SCZ studies, we also collated information from studies of autism (3,446 NS mutations, 579 LoF, from 3,985 trios)93–95, intellectual disability (259 NS, 67 LoF, 192 trios)96–98, and epilepsy (341 NS, 58 LoF, 356 trios)99. However, these additional datasets were only used to test enrichment of genes in GWAS loci that were prioritized by eQTL), not for overlap with differential expression.
